Chemically engineered photoreceptors for vision restoration in retinal degeneration associated blindness.

  • Post author:
  • Post category:

Research Objective This proposal will develop a cell-based therapy that can restore vision in retinal degeneration associated blindness such as Stargardt disease and age-related macular degeneration. Impact Chemically induced method…

Continue ReadingChemically engineered photoreceptors for vision restoration in retinal degeneration associated blindness.

Developing gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models

  • Post author:
  • Post category:

Research Objective We will develop a gene therapy for a major inherited optic nerve disease and test the effectiveness of the treatment by analyzing healthy and patient stem cell-derived mini…

Continue ReadingDeveloping gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models

Microenvironment based optimization of retinal induction using CRISPR-CAS9 reporter pluripotent stem cells as an expandable source of retinal progenitors and photoreceptors.

  • Post author:
  • Post category:

Research Objective To increase the efficiency of generating pure retinal progenitor cultures for use in transplantation and to probe general aspects of retinal development. Impact Our methods could increase the…

Continue ReadingMicroenvironment based optimization of retinal induction using CRISPR-CAS9 reporter pluripotent stem cells as an expandable source of retinal progenitors and photoreceptors.

AAV Gene Therapy for Treating Congenital Hereditary Endothelial Dystrophy associated with Biallelic SLC4A11 Mutations

  • Post author:
  • Post category:

Translational Candidate Therapeutic candidate rAAV8-EF1α-hSLC4A11 is a recombinant AAV vector with single-stranded cDNA encoding the wild-type human SLC4A11 protein. Area of Impact The candidate is for treatment of congenital hereditary…

Continue ReadingAAV Gene Therapy for Treating Congenital Hereditary Endothelial Dystrophy associated with Biallelic SLC4A11 Mutations